Relaxation, Stress Management Have Short-Term Benefit for Hypertension
By Elana Gotkine HealthDay Reporter
FRIDAY, April 11, 2025 -- Relaxation and stress management techniques have short-term beneficial effects for people with hypertension, according to a systematic review and network meta-analysis published online April 7 in BMJ Medicine.
Katie E. Webster, B.M., B.Ch., D.Phil., from the University of Bristol in the United Kingdom, and colleagues conducted a systematic review and network meta-analysis to examine whether relaxation and stress management techniques are useful for reducing blood pressure in hypertension (blood pressure ≥140/90 mm Hg) and prehypertension (blood pressure ≥120/80 mm Hg). Data were included for 182 studies: 166 for hypertension and 16 for prehypertension.
The researchers found that most relaxation interventions seemed to have a beneficial effect on systolic and diastolic blood pressure at short-term follow-up (≤3 months) for individuals with hypertension. Moderate between-study heterogeneity was seen. Moderate reductions in systolic blood pressure were seen for breathing control, meditation, meditative movement, mindfulness, music, progressive muscle relaxation, psychotherapy, and multicomponent interventions compared with a passive comparator (mean differences, –6.65, –7.71, –9.58, –9.90, –6.61, –7.46, –9.83, and –6.78 mm Hg, respectively). There were also reductions in diastolic blood pressure. The effects on blood pressure seemed to lessen over time, although few studies conducted follow-up for more than three months. Limited data were available for prehypertension, with small effects on systolic blood pressure for short-term follow-up comparing the effects of relaxation therapies with a passive comparator (mean difference, –3.84 mm Hg for meditative movement and –0.53 mm Hg for a multicomponent intervention).
"The results of our study indicated that many relaxation interventions show promise for reducing blood pressure in the short term, but the longer-term effects are unclear," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
GLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension
MONDAY, July 21, 2025 -- For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved...
ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension
FRIDAY, July 18, 2025 -- All individuals with hypertension should be screened for primary aldosteronism (PA), according to a clinical practice guideline issued by the Endocrine...
Delays in HTN Diagnosis Linked to Delays in Medication Prescribing
THURSDAY, July 17, 2025 -- Delays in diagnosis of hypertension are common and associated with delays in treatment initiation, according to a study published online July 14 in JAMA...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.